{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:36:28Z","timestamp":1775910988928,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrc.2025.151471","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T07:42:06Z","timestamp":1739259726000},"page":"151471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment"],"prefix":"10.1016","volume":"753","author":[{"given":"Venkatesan","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathiya Priya","family":"Palani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath Kumar","family":"Chagaleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Ze","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana Gopi","family":"Valsaladevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-2730","authenticated-orcid":false,"given":"Kathiravan Muthu","family":"Kumaradoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151471_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bbrc.2025.151471_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/13543776.2013.778246","article-title":"Carbonic anhydrase inhibitors: an editorial","volume":"23","author":"Supuran","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbrc.2025.151471_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","article-title":"Structure and mechanism of carbonic anhydrase","volume":"74","author":"Lindskog","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151471_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mpev.1996.0006","article-title":"Functional diversity, conservation, and convergence in the evolution of the \u03b1-, \u03b2-, and \u03b3-carbonic anhydrase gene families","volume":"5","author":"Hewett-Emmett","year":"1996","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.bbrc.2025.151471_bib5","first-page":"77","article-title":"Prokaryotic carbonic anhydrases of earth\u2019s environment","author":"Kumar","year":"2014","journal-title":"Carbon. Anhydr.: Mech. Regulat. Link Dise. Industr. Appl."},{"key":"10.1016\/j.bbrc.2025.151471_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.advenzreg.2009.10.005","article-title":"Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration","volume":"50","author":"Chiche","year":"2010","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.bbrc.2025.151471_bib7","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2025.151471_bib8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2174\/138161208783877929","article-title":"The beta and gamma classes of carbonic anhydrase","volume":"14","author":"Zimmerman","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2025.151471_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151471_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004180000181","article-title":"Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours","volume":"114","author":"Kivel\u00e4","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151471_bib11","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.151471_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1215\/15228517-2007-001","article-title":"Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy","volume":"9","author":"Haapasalo","year":"2007","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2025.151471_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrc.2025.151471_bib15","series-title":"Drug Design of Zinc\u2010Enzyme Inhibitors","first-page":"138","article-title":"X\u2010Ray crystallography of carbonic anhydrase inhibitors and its importance in drug design","author":"Alterio","year":"2009"},{"key":"10.1016\/j.bbrc.2025.151471_bib16","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/ph17020195","article-title":"Targeting hypoxia-inducible factor-1 (HIF-1) in cancer: emerging therapeutic strategies and pathway regulation","volume":"17","author":"Qannita","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2025.151471_bib18","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151471_bib19","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2025.151471_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbrc.2025.151471_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/chin.199213062","article-title":"ChemInform abstract: unexpected pH\u2010dependent conformation of his\u201064, the proton shuttle of carbonic anhydrase II","volume":"23","author":"Nair","year":"1992","journal-title":"ChemInform"},{"key":"10.1016\/j.bbrc.2025.151471_bib22","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1021\/bi00445a054","article-title":"Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant","volume":"28","author":"Tu","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2025.151471_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2025.151471_bib24","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1039\/D3RA08618F","article-title":"Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX","volume":"14","author":"Saravanan","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.151471_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.18311\/jnr\/2024\/36071","article-title":"Exploring natural product derivatives having carbonic anhydrase inhibitory activity","author":"Packiapalavesam","year":"2024","journal-title":"J. Nat. Remedies"},{"key":"10.1016\/j.bbrc.2025.151471_bib26","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2025.151471_bib27","doi-asserted-by":"crossref","first-page":"38079","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.151471_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cem.2574","article-title":"3D CoMFA, CoMSIA, topomer CoMFA and HQSAR studies on aromatic acid esters for carbonic anhydrase inhibitory activity","volume":"28","author":"Nilewar","year":"2014","journal-title":"J. Chemom."},{"key":"10.1016\/j.bbrc.2025.151471_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/cem.3189","article-title":"QSAR and docking studies on Triazole Benzene Sulfonamides with human Carbonic anhydrase IX inhibitory activity","volume":"33","author":"Gopinath","year":"2019","journal-title":"J. Chemom."},{"key":"10.1016\/j.bbrc.2025.151471_bib30","series-title":"Machine Learning and Systems Biology in Genomics and Health","first-page":"189","article-title":"Artificial intelligence and its application in cardiovascular disease management","author":"Namasivayam","year":"2022"},{"key":"10.1016\/j.bbrc.2025.151471_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108073","article-title":"Identification of novel CA IX inhibitor: pharmacophore modeling, docking, DFT, and dynamic simulation","volume":"110","author":"Packiapalavesam","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib32","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1080\/07391102.2023.2193985","article-title":"An overview of mechanism and chemical inhibitors of shikimate kinase","volume":"41","author":"Chagaleti","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.151471_bib33","first-page":"5304","article-title":"Molecular modelling investigation on 4-aminoquinoline derivatives as potent anti-tubercular agents","volume":"11","author":"Kathiravan","year":"2022","journal-title":"J. Med. Pharmaceut. All. Sci."},{"key":"10.1016\/j.bbrc.2025.151471_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/14756366.2017.1380638","article-title":"Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors","volume":"32","author":"Ramya","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib37","series-title":"Metalloenzymes","first-page":"139","article-title":"Carbonic anhydrases","author":"Supuran","year":"2024"},{"key":"10.1016\/j.bbrc.2025.151471_bib38","series-title":"Bioinformatics for Everyone","first-page":"47","article-title":"Multiple sequence alignment","author":"Sofi","year":"2022"},{"key":"10.1016\/j.bbrc.2025.151471_bib39","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.1093\/nar\/gkh435","article-title":"BLAST: at the core of a powerful and diverse set of sequence analysis tools","volume":"32","author":"McGinnis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.151471_bib40","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1080\/07391102.2021.1936179","article-title":"Identification of potential inhibitors for LLM of Staphylococcus aureus : structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies","volume":"40","author":"Kumari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.151471_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132476","article-title":"Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus","volume":"1255","author":"Kumari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.procbio.2024.04.012","article-title":"Furan-based chalcone protects \u03b2-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-\u03b3) signaling","volume":"142","author":"Nayak","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.bbrc.2025.151471_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140385","article-title":"Exploring the cyclization of thiosemicarbazone to 1,3,4-thiadiazole: synthesis, characterization and in-silico study","volume":"1322","author":"Mukhrish","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139116","article-title":"Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: synthesis, characterization, and computational study","volume":"1317","author":"Laamari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140060","article-title":"Thymol-1,2,3-triazole derivatives: network pharmacology, molecular simulations and synthesis targeting breast cancer","volume":"1321","author":"Laamari","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2024.103220","article-title":"Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis","volume":"36","author":"Shanthakumar","year":"2024","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.bbrc.2025.151471_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/biomedicines12040788","article-title":"Dual anti-inflammatory and anticancer activity of novel 1,5-diaryl pyrazole derivatives: molecular modeling, synthesis, in vitro activity, and dynamics study","volume":"12","author":"Deivasigamani","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.151471_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2019.1580616","article-title":"Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1\u03b1 and p300","volume":"38","author":"Yu","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.151471_bib50","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1021\/acs.jctc.1c00114","article-title":"Metadynamics-based approaches for modeling the hypoxia-inducible factor 2\u03b1 ligand binding process","volume":"17","author":"Callea","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2025.151471_bib51","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41598-018-20971-4","article-title":"Molecular dynamic simulations reveal structural insights into substrate and inhibitor binding modes and functionality of Ecto-Nucleoside Triphosphate Diphosphohydrolases","volume":"8","author":"Iqbal","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.151471_bib52","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1016\/j.bmc.2018.05.035","article-title":"Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: insights into isoenzyme selectivity","volume":"26","author":"Richards","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151471_bib53","doi-asserted-by":"crossref","first-page":"33770","DOI":"10.1039\/D3RA05672D","article-title":"Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach","volume":"13","author":"Chagaleti","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.151471_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139116","article-title":"Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: synthesis, characterization, and computational study","volume":"1317","author":"Laamari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphys.2021.111281","article-title":"Molecular modelling of two coordination states of Zn(II) ion at the active site of human carbonic anhydrase II","volume":"549","author":"Paul","year":"2021","journal-title":"Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.151471_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.151471_bib57","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1039\/c3cp00116d","article-title":"Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations","volume":"15","author":"Godschalk","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.151471_bib58","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1093\/nar\/gkz499","article-title":"Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations","volume":"47","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.151471_bib59","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1021\/acs.jcim.2c00961","article-title":"Decoding the identification mechanism of an SAM-III riboswitch on ligands through multiple independent Gaussian-accelerated molecular dynamics simulations","volume":"62","author":"Chen","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.151471_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100769","article-title":"Rational design of some 1,3,4 trisubstituted pyrazole-thiazole derivatives to serve as MtInhA inhibitors using QSAR, ADMET, molecular docking, MM-GBSA, and molecular dynamics simulations approach","volume":"9","author":"Mhetre","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.bbrc.2025.151471_bib61","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1080\/07391102.2021.1936179","article-title":"Identification of potential inhibitors for LLM of Staphylococcus aureus : structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies","volume":"40","author":"Kumari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.151471_bib62","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1021\/acs.jcim.2c00057","article-title":"Quantum mechanics\/molecular mechanics studies on the catalytic mechanism of a novel esterase (FmtA) of Staphylococcus aureus","volume":"62","author":"Dalal","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.151471_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132476","article-title":"Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus","volume":"1255","author":"Kumari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151471_bib64","doi-asserted-by":"crossref","first-page":"17440","DOI":"10.1039\/D1CP02891J","article-title":"Theoretical assessments on the interaction between amino acids and the g-Mg 3 N 2 monolayer: dispersion corrected DFT and DFT-MD simulations","volume":"23","author":"Rezvani","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.151471_bib65","doi-asserted-by":"crossref","first-page":"21492","DOI":"10.1039\/D3CP01490H","article-title":"Toward functionalization of ZnO nanotubes and monolayers with 5-aminolevulinic acid drugs as possible nanocarriers for drug delivery: a DFT based molecular dynamic simulation","volume":"25","author":"Mohammadzaheri","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.151471_bib66","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1021\/acs.jcim.2c00057","article-title":"Quantum mechanics\/molecular mechanics studies on the catalytic mechanism of a novel esterase (FmtA) of Staphylococcus aureus","volume":"62","author":"Dalal","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.151471_bib67","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1080\/07391102.2021.1916597","article-title":"In-silico screening and identification of potential inhibitors against 2Cys peroxiredoxin of Candidatus Liberibacter asiaticus","volume":"40","author":"Gupta","year":"2022","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25001858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25001858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:45:47Z","timestamp":1740743147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25001858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":67,"alternative-id":["S0006291X25001858"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151471","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151471"}}